# Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ca-23-038-integrating-health-disparities-into-immuno-oncology-hdio-p20/  
Official notice: https://www.grants.gov/search-results-detail/347802

> National Institutes of Health offered grants of up to $250,000 to nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. Applications closed on June 30, 2023.

| Field | Value |
|---|---|
| Opportunity number | RFA-CA-23-038 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | June 30, 2023 |
| Award ceiling | $250,000 |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.393 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

## What the grant funds

The scientific objectives of this P20 FOA are to support planning and feasibility studies to integrate cancer health disparities into immuno-oncology research studies. The P20 project will enable complementary, multi-disciplinary research teams to address inter-disciplinary research to integrate cancer health disparities into immuno-oncology research. It is anticipated these feasibility or pilot studies will support the exploration of novel or high-risk research hypotheses.

## Questions people ask

### Is RFA-CA-23-038 still open?

No. It closed on June 30, 2023.

### Who can apply for Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed)?

National Institutes of Health accepted applications from nonprofits, colleges and universities, state and local governments, tribes, small businesses and businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed)?

Closed June 30, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $250,000 each.

### Who has been funded under RFA-CA-23-038?

NIH RePORTER lists 4 projects funded under RFA-CA-23-038 in fiscal 2024 to 2025, at 4 institutions. The most were at Sloan-Kettering Inst Can Research, University of Southern California, Wayne State University.

### Who has won Cancer Cause and Prevention Research grants before?

The largest recipients over five fiscal years were The Univeristy of Texas M.D. Anderson Cancer Center, Sloan-Kettering Institute for Cancer Research, The Trustees of Columbia University in the City of New York. The program made 2,517 awards worth $3.6 billion in that time.